Detalhe da pesquisa
1.
Assessing interactions for fixed-dose drug combinations in tumor xenograft studies.
J Biopharm Stat
; 22(3): 535-43, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22416839
2.
MicroRNA-34a is a potent tumor suppressor molecule in vivo in neuroblastoma.
BMC Cancer
; 11: 33, 2011 Jan 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-21266077
3.
A high-throughput study in melanoma identifies epithelial-mesenchymal transition as a major determinant of metastasis.
Cancer Res
; 67(7): 3450-60, 2007 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17409456
4.
IFN-beta sensitizes neuroblastoma to the antitumor activity of temozolomide by modulating O6-methylguanine DNA methyltransferase expression.
Mol Cancer Ther
; 7(12): 3852-8, 2008 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19056675
5.
Somatic hypermutation signature in B-cell low-grade lymphomas.
Haematologica
; 93(8): 1186-94, 2008 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-18556400
6.
Transcriptional response of T cells to IFN-alpha: changes induced in IFN-alpha-sensitive and resistant cutaneous T cell lymphoma.
J Interferon Cytokine Res
; 24(3): 185-95, 2004 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-15035852
7.
MicroRNA-542-5p as a novel tumor suppressor in neuroblastoma.
Cancer Lett
; 303(1): 56-64, 2011 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21310526
8.
MicroRNA-184-mediated inhibition of tumour growth in an orthotopic murine model of neuroblastoma.
Anticancer Res
; 30(11): 4391-5, 2010 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21115884
9.
Tyrosine kinase inhibitor gefitinib enhances topotecan penetration of gliomas.
Cancer Res
; 70(11): 4499-508, 2010 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20460504
10.
IFN-beta restricts tumor growth and sensitizes alveolar rhabdomyosarcoma to ionizing radiation.
Mol Cancer Ther
; 9(3): 761-71, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20197402
11.
Postdocs: NPA's success.
Science
; 336(6089): 1638, 2012 Jun 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-22745398
12.
Expression of SMARCB1 modulates steroid sensitivity in human lymphoblastoid cells: identification of a promoter SNP that alters PARP1 binding and SMARCB1 expression.
Hum Mol Genet
; 16(19): 2261-71, 2007 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17616514
13.
Expression of the NF-kappaB targets BCL2 and BIRC5/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively.
J Pathol
; 206(2): 123-34, 2005 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-15880597
14.
Mycosis fungoides shows concurrent deregulation of multiple genes involved in the TNF signaling pathway: an expression profile study.
Blood
; 102(3): 1042-50, 2003 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12689942
15.
Identification of genes involved in resistance to interferon-alpha in cutaneous T-cell lymphoma.
Am J Pathol
; 161(5): 1825-37, 2002 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-12414529